FIA
DNA icon

FNY Investment Advisers’s Ginkgo Bioworks DNA Stock Holding History

FNY Investment Advisers’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26
Closed -$1K – 609
2022
Q4 		$1K Buy
+26
New +$2.39K ﹤0.01% 443

Other funds holding DNA

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return

FNY Investment Advisers's DNA Position: Q2 2026 in Review

FNY Investment Advisers reduced its Ginkgo Bioworks (DNA) stake by 2.7% in Q2 2026, selling an estimated $3.46K and leaving 14,966 shares worth $148K. The position accounts for 0.05% of the portfolio, ranked #277.

FNY Investment Advisers first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.69M in Q2 2025. 49 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • FNY Investment Advisers held 14,966 shares of Ginkgo Bioworks worth $148K as of Q2 2026.
  • FNY Investment Advisers sold 414 Ginkgo Bioworks shares in Q2 2026, an estimated $3.46K.
  • Ginkgo Bioworks made up 0.05% of FNY Investment Advisers's portfolio in Q2 2026, its #277 holding.
  • FNY Investment Advisers first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • FNY Investment Advisers's Ginkgo Bioworks position peaked at $1.69M in Q2 2025.
  • 49 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.